Orthometrix, Inc.
OMRX · OTC
12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2007 | |
|---|---|---|---|---|
| Revenue | $2 | $1 | $1 | $2 |
| % Growth | 42.7% | 64.8% | -73% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $1 |
| Gross Profit | $1 | $1 | $0 | $1 |
| % Margin | 69.6% | 69% | 61.7% | 44.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$1 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | $0 | -$0 | $0 |
| % Margin | 17.2% | 11.9% | -22.1% | 17.3% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$1 |
| Pre-Tax Income | $0 | $0 | -$0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | -$0 | -$1 |
| % Margin | 27.2% | 5.4% | -35.4% | -44.7% |
| EPS | 0.008 | 0.001 | -0.004 | -0.02 |
| % Growth | 609.1% | 125% | 78% | – |
| EPS Diluted | 0.008 | 0.001 | -0.004 | -0.02 |
| Weighted Avg Shares Out | 53 | 53 | 53 | 45 |
| Weighted Avg Shares Out Dil | 53 | 53 | 53 | 45 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 31.8% | 12.1% | -21.5% | -16.4% |